Overview
Ling-na Kong practices practicing medicine in Chongqing, China.
Kong is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Hepatitis B, Hepatitis, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).
They are actively involved in clinical research, co-authoring 44 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ling-na X. Kong
Is Ling-na X. Kong a top-rated expert for Hepatitis B?
MediFind is an objective health platform that identifies experts based on real-world data. Ling-na X. Kong is classified as an Advanced expert for Hepatitis B, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ling-na X. Kong participate in research or clinical trials?
Yes. Ling-na X. Kong has published 44 articles and abstracts on conditions like Hepatitis B. You can view a list of Ling-na X. Kong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hepatitis BKong isAdvanced. Learn about Hepatitis B.
- Experienced
- HepatitisKong isExperienced. Learn about Hepatitis.
- Maturity Onset Diabetes of the Young
- Type 2 Diabetes (T2D)Kong isExperienced. Learn about Type 2 Diabetes (T2D).